These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

43 related items for PubMed ID: 2213557

  • 1. Use of monoclonal antibodies as probes for the structure and biological activity of botulinum neurotoxin.
    Simpson LL, Kamata Y, Kozaki S.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):227-32. PubMed ID: 2213557
    [Abstract] [Full Text] [Related]

  • 2. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL, Dasgupta BR.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [Abstract] [Full Text] [Related]

  • 3. The study of clostridial and related toxins. The search for unique mechanisms and common denominators.
    Simpson LL.
    J Physiol (Paris); 1990 Jan; 84(2):143-51. PubMed ID: 2290129
    [Abstract] [Full Text] [Related]

  • 4. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
    [Abstract] [Full Text] [Related]

  • 5. [Structure and function of botulinum toxin].
    Fujii N.
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [Abstract] [Full Text] [Related]

  • 6. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological experiments on the binding and internalization of the 50,000 dalton carboxyterminus of tetanus toxin at the cholinergic neuromuscular junction.
    Simpson LL.
    J Pharmacol Exp Ther; 1985 Jul; 234(1):100-5. PubMed ID: 2409271
    [Abstract] [Full Text] [Related]

  • 8. Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
    Bakry N, Kamata Y, Sorensen R, Simpson LL.
    J Pharmacol Exp Ther; 1991 Aug; 258(2):613-9. PubMed ID: 1865360
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic and possible therapeutic application of a monoclonal antibody (14G8) directed against botulinum type C neurotoxin.
    Montgomery VA, Smith LA.
    Hybridoma (Larchmt); 2011 Jun; 30(3):209-16. PubMed ID: 21707354
    [Abstract] [Full Text] [Related]

  • 10. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
    Coffield JA, Bakry N, Zhang RD, Carlson J, Gomella LG, Simpson LL.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
    [Abstract] [Full Text] [Related]

  • 11. Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization.
    Marks JD.
    Mov Disord; 2004 Mar; 19 Suppl 8():S101-8. PubMed ID: 15027061
    [Abstract] [Full Text] [Related]

  • 12. Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells.
    Maksymowych AB, Simpson LL.
    J Pharmacol Exp Ther; 2004 Aug; 310(2):633-41. PubMed ID: 15140915
    [Abstract] [Full Text] [Related]

  • 13. Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments.
    Joshi SG, Elias M, Singh A, Al-Saleem FH, Ancharski D, Nasser Z, Takahashi T, Simpson LL.
    Neuroscience; 2011 Apr 14; 179():208-22. PubMed ID: 21277940
    [Abstract] [Full Text] [Related]

  • 14. Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies.
    Schoepe H, Wieler LH, Bauerfeind R, Schlapp T, Potschka H, Hehnen HR, Baljer G.
    Microb Pathog; 1997 Jul 14; 23(1):1-10. PubMed ID: 9250775
    [Abstract] [Full Text] [Related]

  • 15. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
    Simpson LL.
    J Pharmacol Exp Ther; 1984 Apr 14; 229(1):182-7. PubMed ID: 6707933
    [Abstract] [Full Text] [Related]

  • 16. Production of polyclonal antibodies in mice against cobratoxin, botulinum toxin and ricin without altering their toxicity or use of adjuvant.
    Lipps BV.
    J Nat Toxins; 2001 Feb 14; 10(1):27-32. PubMed ID: 11288726
    [Abstract] [Full Text] [Related]

  • 17. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S, Bartoszcze M, Gryko R.
    Przegl Epidemiol; 2007 Feb 14; 61(3):519-27. PubMed ID: 18069389
    [Abstract] [Full Text] [Related]

  • 18. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
    Kalandakanond S, Coffield JA.
    J Pharmacol Exp Ther; 2001 Mar 14; 296(3):980-6. PubMed ID: 11181932
    [Abstract] [Full Text] [Related]

  • 19. Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA.
    Stanker LH, Merrill P, Scotcher MC, Cheng LW.
    J Immunol Methods; 2008 Jul 20; 336(1):1-8. PubMed ID: 18452945
    [Abstract] [Full Text] [Related]

  • 20. Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.
    Wu HC, Yeh CT, Huang YL, Tarn LJ, Lung CC.
    Appl Environ Microbiol; 2001 Jul 20; 67(7):3201-7. PubMed ID: 11425742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.